Promoting Ontario's Biotech Industry on the World Stage
Ontario Pavilion Opens at 2013 BIO International Convention
Ontario is showcasing its life sciences and biotechnology strength at this year's BIO International Convention in Chicago, Illinois.
The annual conference gives opportunities for Ontario companies to promote the province's strong life sciences and biotechnology sectors on an international stage. Yesterday, four companies or organizations announced initiatives that will support cutting-edge research in Ontario:
- MERCK announced $4 million to accelerate drug research and commercialization for three academic incubators in Canada, including MaRS Innovation
- MaRS Innovation announced the formation of a strategic partnership with Pfizer Inc. to advance early-stage technologies related to human health in therapeutics and diagnostics
- The Ontario Institute for Cancer Research is collaborating with Janssen Inc. to find and test new biomarkers to identify patients at high risk for disease progression and biomarkers of response to therapy
- Armour Therapeutics announced encouraging results in the development of new prostate cancer fighting drugs.
A vibrant life sciences sector helps create good jobs, a strong economy and a fair society for the people of the province.
- Ontario is the largest life sciences jurisdiction in Canada with approximately 50 per cent of the country’s life sciences economic activity.
- Since 2003, the Ontario government has invested $3.6 billion in research and innovation across the province.
- Ontario’s medical devices sector generated $3.6 billion in revenues in 2011.
“The calibre of the Ontario talent and the companies being showcased in Chicago highlights why our province is a leader in the biotech industry. Our government is committed to support for this sector and ensuring that it will continue to create high-paying jobs and leading-edge care for Ontarians.”
“This week at BIO 2013 we are celebrating the innovation and collaboration taking place between Illinois and Ontario in the biotechnology industry. By working together, we are creating economic opportunities on both sides of the border in this important and growing sector.”